Abbott Laboratories (ABT) Current Assets (2009 - 2026)

Abbott Laboratories' Current Assets history runs 18 years deep, the most recent figure standing at $25.5 billion for Q1 2026.

• In Q1 2026, Current Assets rose 10.17% year-over-year to $25.5 billion; the TTM figure through Mar 2026 stood at $25.5 billion (up 10.17% YoY), while the FY2025 annual figure was $26.0 billion, up 9.89% from the prior year.
• Current Assets came in at $25.5 billion for Q1 2026 at Abbott Laboratories, down from $26.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $26.0 billion in Q4 2025 to a low of $22.4 billion in Q1 2024.
• A 5-year average of $24.0 billion and a median of $23.8 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets grew 10.29% in 2022 and retreated 10.13% in 2023, its largest moves.
• Abbott Laboratories' Current Assets stood at $25.2 billion in 2022, then declined by 10.13% to $22.7 billion in 2023, then grew by 4.35% to $23.7 billion in 2024, then rose by 9.89% to $26.0 billion in 2025, then retreated by 1.88% to $25.5 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $25.5 billion, $26.0 billion, and $24.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison